|View printer-friendly version|
|January 27, 2006 1:25 p.m.|
|Teva Announces Pricing of $1.5 Billion of Senior Notes|
Jerusalem, Israel, January 27, 2006 - Teva Pharmaceutical Industries Limited (Nasdaq: TEVA) announced today that it priced the offering, by its special purpose finance subsidiary, of $500 million of 5.550% senior notes maturing in 2016 and $1 billion of 6.150% senior notes maturing in 2036. These notes will be guaranteed by Teva.